发明授权
US09309250B2 Substituted pyrrolo[2,3-b]pyrazines as ATR kinase inhibitors 有权
取代的吡咯并[2,3-b]吡嗪作为ATR激酶抑制剂

Substituted pyrrolo[2,3-b]pyrazines as ATR kinase inhibitors
摘要:
The present invention relates to pyrrolopyrazines compounds useful as inhibitors of ATR protein kinase. The invention also relates to pharmaceutically acceptable compositions comprising the compounds of this invention; methods of treating of various diseases, disorders, and conditions using the compounds of this invention; processes for preparing the compounds of this invention; intermediates for the preparation of the compounds of this invention; and methods of using the compounds in in vitro applications, such as the study of kinases in biological and pathological phenomena; the study of intracellular signal transduction pathways mediated by such kinases; and the comparative evaluation of new kinase inhibitors.The compounds of this invention have formula I: wherein the variables are as defined herein.
公开/授权文献
信息查询
0/0